ArticleCurrent Alzheimer research2024

Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Daniel P Radin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.